The financial toxicity of cancer care in India
“Sir, I don’t have the money for the test,” said Vijay, a low-income lung cancer patient from Hyderabad. His oncologist replied, “Without the money, he has only a few months left.” The test — a 12-gene next-generation DNA sequencing panel — could have guided a life-saving treatment plan. Genomics-informed precision medicine, or targeted therapy, offers
The financial toxicity of cancer care in India Read More »